Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flurpiridaz F-18 PET/CT for Detecting Parathyroid Adenomas
NCT07910097Phase 1Recruiting
- Sponsor
- University of Pennsylvania
- Start
- Aug 2026
- Primary completion
- Sep 2028
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial in primary hyperparathyroidism (PHPT), sponsored by University of Pennsylvania. Primary endpoint: Diagnostic Sensitivity at 6 weeks. Started Aug 2026; status: recruiting.
02
Conditions
primary hyperparathyroidism (PHPT)
Beyond the preview
Go deeper on NCT07910097.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07910097.